Establishment of an experimental model of ovalbumin-induced atopic dermatitis in canines

IntroductionA reliable standard model is required to evaluate the efficacy of new drugs for companion animals, especially dogs. Canine atopic dermatitis (cAD), also known as allergic inflammatory skin disease, is a common condition. Currently, the house dust mite animal model is used in the research...

Full description

Bibliographic Details
Main Authors: Ha-Young Shin, Hyung Jun Jin, Hyun-Jin Tae, Hong-Geun Oh, Jeong Ho Hwang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2024.1296138/full
_version_ 1797352586567745536
author Ha-Young Shin
Ha-Young Shin
Hyung Jun Jin
Hyung Jun Jin
Hyun-Jin Tae
Hong-Geun Oh
Jeong Ho Hwang
Jeong Ho Hwang
author_facet Ha-Young Shin
Ha-Young Shin
Hyung Jun Jin
Hyung Jun Jin
Hyun-Jin Tae
Hong-Geun Oh
Jeong Ho Hwang
Jeong Ho Hwang
author_sort Ha-Young Shin
collection DOAJ
description IntroductionA reliable standard model is required to evaluate the efficacy of new drugs for companion animals, especially dogs. Canine atopic dermatitis (cAD), also known as allergic inflammatory skin disease, is a common condition. Currently, the house dust mite animal model is used in the research of cAD; however, this model exhibits significant individual variation and is difficult to standardize. In this study, we used ovalbumin as an antigen to sensitize and stimulate dogs, thereby establishing a stable model mimicking the T-helper 2 (Th2) response seen in cAD. Our objective was to create a cAD model that could be employed to evaluate the efficacy of novel drugs and mimic the Th2 dominant allergic response observed in the pathogenesis of atopic dermatitis of dogs.MethodsIn this study, six beagles were used. Normal saline was applied to two animals, and ovalbumin to four, on their dorsal skin.ResultsThe ovalbumin-treated groups exhibited clinical cAD symptoms, such as pruritus and erythema. Moreover, plasma levels of the cAD markers immunoglobulin E and CCL17 chemokine were higher in the ovalbumin-treated group than in the vehicle control group. The skin thickness of the epidermis was significantly increased in the ovalbumin-treated group, with infiltration of inflammatory cells observed in the thickened dermis region. In conclusion, treatment of canine skin with an optimal concentration of ovalbumin induced typical cAD-like symptoms, and histological and molecular analyses confirmed an enhanced Th2-related immune response.ConclusionTherefore, we successfully established a suitable Th2-dominant response mimicking cAD, which will facilitate targeted research of atopic dermatitis in dogs.
first_indexed 2024-03-08T13:19:03Z
format Article
id doaj.art-cd69eacc93a44e27b0efaeb59807ca4c
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-03-08T13:19:03Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-cd69eacc93a44e27b0efaeb59807ca4c2024-01-18T04:29:47ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692024-01-011110.3389/fvets.2024.12961381296138Establishment of an experimental model of ovalbumin-induced atopic dermatitis in caninesHa-Young Shin0Ha-Young Shin1Hyung Jun Jin2Hyung Jun Jin3Hyun-Jin Tae4Hong-Geun Oh5Jeong Ho Hwang6Jeong Ho Hwang7Animal Model Research Group, Korea Institute of Toxicology, Jeongeup, Republic of KoreaCompanion Animal New Drug Development Center, Korea Institute of Toxicology, Jeongeup, Republic of KoreaAnimal Model Research Group, Korea Institute of Toxicology, Jeongeup, Republic of KoreaCollege of Veterinary Medicine and Biosafety Research Institute, Jeonbuk National University, Iksan, Jeollabuk-do, Republic of KoreaCompanion Animal New Drug Development Center, Korea Institute of Toxicology, Jeongeup, Republic of KoreaR&D Division, HUVET Co., Ltd., Iksan-si, Republic of KoreaAnimal Model Research Group, Korea Institute of Toxicology, Jeongeup, Republic of KoreaCollege of Veterinary Medicine and Biosafety Research Institute, Jeonbuk National University, Iksan, Jeollabuk-do, Republic of KoreaIntroductionA reliable standard model is required to evaluate the efficacy of new drugs for companion animals, especially dogs. Canine atopic dermatitis (cAD), also known as allergic inflammatory skin disease, is a common condition. Currently, the house dust mite animal model is used in the research of cAD; however, this model exhibits significant individual variation and is difficult to standardize. In this study, we used ovalbumin as an antigen to sensitize and stimulate dogs, thereby establishing a stable model mimicking the T-helper 2 (Th2) response seen in cAD. Our objective was to create a cAD model that could be employed to evaluate the efficacy of novel drugs and mimic the Th2 dominant allergic response observed in the pathogenesis of atopic dermatitis of dogs.MethodsIn this study, six beagles were used. Normal saline was applied to two animals, and ovalbumin to four, on their dorsal skin.ResultsThe ovalbumin-treated groups exhibited clinical cAD symptoms, such as pruritus and erythema. Moreover, plasma levels of the cAD markers immunoglobulin E and CCL17 chemokine were higher in the ovalbumin-treated group than in the vehicle control group. The skin thickness of the epidermis was significantly increased in the ovalbumin-treated group, with infiltration of inflammatory cells observed in the thickened dermis region. In conclusion, treatment of canine skin with an optimal concentration of ovalbumin induced typical cAD-like symptoms, and histological and molecular analyses confirmed an enhanced Th2-related immune response.ConclusionTherefore, we successfully established a suitable Th2-dominant response mimicking cAD, which will facilitate targeted research of atopic dermatitis in dogs.https://www.frontiersin.org/articles/10.3389/fvets.2024.1296138/fullovalbuminatopic dermatitiscanine atopic dermatitisatopic dermatitis animal modelT helper 2 immune response
spellingShingle Ha-Young Shin
Ha-Young Shin
Hyung Jun Jin
Hyung Jun Jin
Hyun-Jin Tae
Hong-Geun Oh
Jeong Ho Hwang
Jeong Ho Hwang
Establishment of an experimental model of ovalbumin-induced atopic dermatitis in canines
Frontiers in Veterinary Science
ovalbumin
atopic dermatitis
canine atopic dermatitis
atopic dermatitis animal model
T helper 2 immune response
title Establishment of an experimental model of ovalbumin-induced atopic dermatitis in canines
title_full Establishment of an experimental model of ovalbumin-induced atopic dermatitis in canines
title_fullStr Establishment of an experimental model of ovalbumin-induced atopic dermatitis in canines
title_full_unstemmed Establishment of an experimental model of ovalbumin-induced atopic dermatitis in canines
title_short Establishment of an experimental model of ovalbumin-induced atopic dermatitis in canines
title_sort establishment of an experimental model of ovalbumin induced atopic dermatitis in canines
topic ovalbumin
atopic dermatitis
canine atopic dermatitis
atopic dermatitis animal model
T helper 2 immune response
url https://www.frontiersin.org/articles/10.3389/fvets.2024.1296138/full
work_keys_str_mv AT hayoungshin establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines
AT hayoungshin establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines
AT hyungjunjin establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines
AT hyungjunjin establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines
AT hyunjintae establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines
AT honggeunoh establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines
AT jeonghohwang establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines
AT jeonghohwang establishmentofanexperimentalmodelofovalbumininducedatopicdermatitisincanines